Skip to search formSkip to main content
Semantic Scholar is currently undergoing maintenance, some functionality may be limited.
You are currently offline. Some features of the site may not work correctly.

Onercept

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
  • Kim A. Papp
  • Current medical research and opinion
  • 2010
  • Corpus ID: 7081781
Abstract Background: Tumor necrosis factor (TNF)-α plays a critical role in psoriasis pathogenesis, and several anti-TNF agents… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To conduct a robust, double-blind, placebo-controlled study examining the effects of tumor necrosis factor (TNF… Expand
Is this relevant?
2006
2006
BACKGROUND AND AIMS Onercept is a recombinant, soluble human p55 receptor to tumor necrosis factor-alpha. METHODS A randomized… Expand
Is this relevant?
2005
2005
ObjectiveTo develop a population pharmacokinetic model and to determine the covariates affecting the pharmacokinetics of onercept… Expand
Is this relevant?
Review
2004
Review
2004
Inflammatory bowel disease (IBD) is a chronic immunoinflammatory response to an stimulus that activates a chain of cellular… Expand
Is this relevant?
2003
2003
BACKGROUND Monoclonal antibodies to the pro-inflammatory cytokine tumour necrosis factor-alpha have shown efficacy in treating… Expand
Is this relevant?
Review
2003
Review
2003
Onercept is a recombinant human soluble p55 tumor necrosis factor binding protein under development by Serono for the potential… Expand
Is this relevant?
Review
2003
Review
2003
The introduction of infliximab, a mouse/human chimeric monoclonal antibody to tumor necrosis factor (TNF), is an important… Expand
Is this relevant?
2003
2003
  • 2003
  • Corpus ID: 195137095
 
Is this relevant?
2001
2001
The safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (r-hTBP-1… Expand
Is this relevant?